Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Aug 5, 2022
Date Accepted: Aug 1, 2023
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A Narrow Definition of Clinical Robustness: Comment on “Assessing the Clinical Robustness of Digital Health Startups: Cross-sectional Observational Analysis”
ABSTRACT
This letter to the editor is in response to the article “Assessing the Clinical Robustness of Digital Health Startups: Cross-sectional Observational Analysis” by Day et al. We appreciate the authors highlighting the importance of assessing the quality and impact of the growing digital health industry. However, we found the definition of clinical robustness to be too narrow and not applicable to the broad digital health industry. In this letter, we argue that clinical robustness should also consider accreditations, externally validated methodologies, and peer-reviewed studies demonstrating impact.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.